Effect of adjuvants in the isotypes and bactericidal activity of antibodies against the transferrin-binding proteins of Neisseria meningitidis

被引:9
作者
Gómez, JA [1 ]
Hernández, E [1 ]
Criado, MT [1 ]
Ferreirós, CM [1 ]
机构
[1] Univ Santiago Compostela, Fac Farm, Dept Microbiol & Parasitol, Santiago De Compostela, Spain
关键词
Neisseria meningitidis; adjuvant; transferrin-binding protein; vaccine; TbpA; TbpB;
D O I
10.1016/S0264-410X(98)00062-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Twenty-eight Neisseria meningitidis strains of different serogroups, serotypes, and TbpB isotypes were used to test the effect of five adjuvant formulations on the immune response to the meningococcal transferrin-binding proteins (Tbps) in mice. Levels of anti-Tbps antibodies were relatively low when purified TbpA-TbpB complexes were used for immunization, those obtained with the RAS adjuvant being the highest, and the isotype distribution reveals a prevalence of the non-bactericidal IgG1. Specific anti-Tbps antibody levels were five to 125 times higher immunizing with whole outer membrane vesicles, with bactericidal isotypes prevailing, which suggests that presentation of these antigens in their natural conformation is crucial to elicit a good response. Nevertheless, bactericidal activity did not correlate with these characteristics, confirming that it must be also influenced by other factors, and direct evaluation of the killing ability is necessary to draw conclusions about the efficacy of antigens or adjuvants in vaccine design. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1633 / 1639
页数:7
相关论文
共 31 条
[1]   IMMUNE-RESPONSES IN HUMANS AND ANIMALS TO MENINGOCOCCAL TRANSFERRIN-BINDING PROTEINS - IMPLICATIONS FOR VACCINE DESIGN [J].
ALAALDEEN, DAA ;
STEVENSON, P ;
GRIFFITHS, E ;
GORRINGE, AR ;
IRONS, LI ;
ROBINSON, A ;
HYDE, S ;
BORRIELLO, SP .
INFECTION AND IMMUNITY, 1994, 62 (07) :2984-2990
[2]   The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains [J].
AlaAldeen, DAA ;
Borriello, SP .
VACCINE, 1996, 14 (01) :49-53
[3]   ADJUVANTS - CURRENT STATUS, CLINICAL PERSPECTIVES AND FUTURE-PROSPECTS (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 174-178, 1993) [J].
AUDIBERT, FM ;
LISE, LD .
IMMUNOLOGY TODAY, 1993, 14 (06) :281-284
[4]  
Chase M., 1967, METHODS IMMUNOLOGY I, P197
[5]   IMMUNIZATION WITH A MULTIPLE ANTIGEN PEPTIDE-CONTAINING DEFINED B-CELL AND T-CELL EPITOPES - PRODUCTION OF BACTERICIDAL ANTIBODIES AGAINST GROUP-B NEISSERIA-MENINGITIDIS [J].
CHRISTODOULIDES, M ;
HECKELS, JE .
MICROBIOLOGY-SGM, 1994, 140 :2951-2960
[6]   IMMUNOGENICITY AND ANTIGENIC HETEROGENEITY OF A HUMAN TRANSFERRIN-BINDING PROTEIN IN NEISSERIA-MENINGITIDIS [J].
FERRON, L ;
FERREIROS, CM ;
CRIADO, MT ;
PINTOR, M .
INFECTION AND IMMUNITY, 1992, 60 (07) :2887-2892
[7]  
FERRON L, 1994, FEMS IMMUNOL MED MIC, V9, P299
[8]  
FERRON L, 1993, FEMS MICROBIOL LETT, V109, P159, DOI 10.1016/0378-1097(93)90013-R
[9]  
FLETCHER JN, 1986, J GEN MICROBIOL, V132, P1611
[10]  
FRASCH CE, 1983, MED MICROBIOLOGY, P115